Blog
About

5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found
      Is Open Access

      SAT-130 Prevalence and Management of Hyperglycemia in Patients without Previously Recognised Diabetes Mellitus Presenting to the Emergency Department: A Retrospective Cross-Sectional Study

      , MBBS, , MBBS (Hons), , BN, , MD, FRACP, FRCPA, , MD, PhD, , MBBS, FRACP

      Journal of the Endocrine Society

      Endocrine Society

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Internationally, the prevalence of hyperglycemia among patients without previously known diabetes in the hospital setting is 7-12%, but Australian data are lacking (1,2). It is important to recognise and follow up hyperglycemia since it is associated with increased mortality and may signify a potential diagnosis of underlying diabetes (1,3). Objectives: To determine the prevalence of hyperglycemia without previously recognised diabetes among all patients screened in the Emergency Department (ED). Secondary aims were to describe the extent of further evaluation for new diabetes via HbA1c testing, adequate glucose monitoring, treatment of significant inpatient hyperglycemia and documented follow-up plans. Methods: Since 2015, all presentations to the ED at a tertiary hospital in Melbourne, Australia underwent screening random plasma glucose (RPG) along with their first plasma biochemistry. RPG in all adult ED presentations was evaluated in a retrospective, cross-sectional study from July to December, 2015. All subjects with hyperglycemia (RPG >7.8 mmol/L) were studied. Pre-existing diabetes was excluded using coding data. Medical records were reviewed to correct for coding errors. A random nested cohort of 200 patients without previously recognised diabetes was further evaluated. Blood glucose monitoring was adequate if undertaken for ≥48 hours. RPG >11 mmol/L was considered significant hyperglycemia and was defined as being adequately treated if supplemental/regular insulin and/or other hypoglycemic agents were charted. Planning of follow-up was considered adequate if hyperglycemia was recognised and a management plan documented in the discharge summary. Results: Prevalence of hyperglycemia in patients without previously recognised diabetes among all patients screened in ED was 5.2% (845/16,268). Of these, 79% required hospital admission and significant hyperglycemia occurred in 15.5%. Within the nested cohort, only 7.5% had follow-up HbA1c. New diabetes (HbA1c ≥6.5% + RPG >11mmol/L) was diagnosed in 20% (3/15) undergoing HbA1c testing. Glucose was adequately monitored in only 9.5%. Appropriate treatment of significant hyperglycemia occurred in only 6.5%. Documentation of a follow-up plan was evident in only 2%. Conclusion: Hyperglycemia is common among patients without previously recognised diabetes presenting to ED. Further evaluation with an HbA1c for new diabetes, performing glucose monitoring, treating significant hyperglycemia in hospital and planning follow-up were suboptimal and require improvement. This is a lost opportunity to diagnose diabetes in those at risk. Reference: (1) Umpierrez et al. J Clin Endocrinol Metab. 2002; 87: 978-82, (2) George et al. Diabetic Med 2005; 22: 1766‐69, (3) Krebs et al. NZ Med J 2000; 113: 379‐81.

          Related collections

          Author and article information

          Journal
          J Endocr Soc
          J Endocr Soc
          jes
          Journal of the Endocrine Society
          Endocrine Society (Washington, DC )
          2472-1972
          15 April 2019
          30 April 2019
          : 3
          : Suppl 1 , ENDO 2019 Abstracts - 101st Annual Meeting of the Endocrine Society – March 23 – 26th, 2019 – New Orleans, Louisiana
          Affiliations
          Alfred Health, Melbourne, , Australia
          Alfred Pathology Service, Alfred Health, Melbourne, , Australia
          Endocrinology and Diabetes, Alfred Health, Melbourne, , Australia
          Article
          js.2019-SAT-130
          10.1210/js.2019-SAT-130
          6552004
          Copyright © 2019 Endocrine Society

          This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).

          Categories
          Diabetes Mellitus and Glucose Metabolism
          Beta Cell Health in Diabetes

          Comments

          Comment on this article